Hartford Financial Management’s Regeneron Pharmaceuticals REGN Stock Holding History

Hartford Financial Management’s Portfolio REGN Stock Details REGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.5K	Hold	4	–	–	﹤0.01%	326
2026 Q1	$3.09K	Hold	4	–	–	﹤0.01%	321
2025 Q4	$3.09K	Hold	4	–	–	﹤0.01%	312
2025 Q3	$2.25K	Hold	4	–	–	﹤0.01%	318
2025 Q2	$2.1K	Hold	4	–	–	﹤0.01%	323
2025 Q1	$2.54K	Hold	4	–	–	﹤0.01%	325
2024 Q4	$2.85K	Hold	4	–	–	﹤0.01%	340
2024 Q3	$4.21K	Hold	4	–	–	﹤0.01%	330
2024 Q2	$4.21K	Hold	4	–	–	﹤0.01%	333
2024 Q1	$3.85K	Hold	4	–	–	﹤0.01%	340
2023 Q4	$3.51K	Hold	4	–	–	﹤0.01%	348
2023 Q3	$3.29K	Buy	4 +1	+33%	+$786	﹤0.01%	347
2023 Q2	$2.16K	Hold	3	–	–	﹤0.01%	347
2023 Q1	$2.47K	Buy	+3	New	+$2.26K	﹤0.01%	340
2022 Q3	–	Sell	-10	Closed	-$6K	–	388
2022 Q2	$6K	Hold	10	–	–	﹤0.01%	310
2022 Q1	$7K	Hold	10	–	–	﹤0.01%	311
2021 Q4	$6K	Hold	10	–	–	﹤0.01%	313
2021 Q3	$6K	Hold	10	–	–	﹤0.01%	316
2021 Q2	$6K	Hold	10	–	–	﹤0.01%	323
2021 Q1	$5K	Hold	10	–	–	﹤0.01%	340
2020 Q4	$5K	Buy	+10	New	+$5.4K	﹤0.01%	315
2019 Q1	–	Sell	-20	Closed	-$7K	–	383
2018 Q4	$7K	Hold	20	–	–	﹤0.01%	325
2018 Q3	$8K	Sell	20 -130	-87%	-$49.5K	﹤0.01%	332
2018 Q2	$52K	Hold	150	–	–	0.02%	224
2018 Q1	$51K	Hold	150	–	–	0.03%	176
2017 Q4	$56K	Hold	150	–	–	0.03%	178
2017 Q3	$67K	Hold	150	–	–	0.03%	179
2017 Q2	$73K	Hold	150	–	–	0.03%	177
2017 Q1	$58K	Buy	+150	New	+$55.6K	0.04%	177

Other funds holding REGN

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

Hartford Financial Management's REGN Position: Q2 2026 in Review

Hartford Financial Management held its Regeneron Pharmaceuticals (REGN) position steady in Q2 2026 at 4 shares worth $2.5K. The position accounts for ﹤0.01% of the portfolio, ranked #326.

Hartford Financial Management first reported a position in REGN in Q1 2017 and has held it in 29 quarters since. The position peaked at $73K in Q2 2017. 1,332 funds tracked by Wall St. Rank hold REGN as of Q2 2026.

Hartford Financial Management held 4 shares of Regeneron Pharmaceuticals worth $2.5K as of Q2 2026.
Hartford Financial Management left its Regeneron Pharmaceuticals share count unchanged in Q2 2026.
Regeneron Pharmaceuticals made up ﹤0.01% of Hartford Financial Management's portfolio in Q2 2026, its #326 holding.
Hartford Financial Management first reported a position in Regeneron Pharmaceuticals in Q1 2017 and has held it in 29 quarters since.
Hartford Financial Management's Regeneron Pharmaceuticals position peaked at $73K in Q2 2017.
1,332 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2026.

Based on Hartford Financial Management's 13F filing for Q2 2026, filed 24 Jul 2026.